We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Longevity Predicted by High Naive White Cell Counts

By Labmedica staff writers
Posted on 09 Jul 2008
Naive white blood cell counts have been proposed as a means to predict longevity and even lead to a way for everyone to live longer.

B-cells are vital components of the immune system, producing antibodies to combat foreign invaders, such as bacteria. More...
Unlike mature B-cells, which are primed to attack foes the body has seen before, naive B-cells are ready and waiting to attack microbes not previously encountered. Therefore, the more naive B-cells present the longer someone is likely to be able to keep fighting off new infections, which might prolong life.

Sonya Vasto Ph.D. and her colleagues at the University of Palermo (Italy) took samples of white blood cells from 45 men and women aged between 75 and 90, who all had parents born between 1900 and 1908. They compared the numbers of naïve blood calls from those who had one parent who had reached 100 with those whose parents had died before reaching the average life expectancy for Italians (67 for men and 72 for women).

The two groups differed in the number of naive B-cells, a type of white blood cell that their blood contained. Our main finding was the increase in naive B-cells in individuals who had centenarian parents, said Dr. Vasto, who presented the results at a conference on aging organized by the Methuselah Foundation (Lorton, VA, USA). The conference took place in Los Angeles (CA, USA) from June 27-29, 2008.

Dr. Vasco said, "If people discover they have fewer naive B-cells, they might take extra steps to forestall infections.”


Related Links:
University of Palermo
Methuselah Foundation

Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Influenza Virus Test
NovaLisa Influenza Virus B IgM ELISA
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.